Cristian Massacesi - 10 Mar 2026 Form 4 Insider Report for BRISTOL MYERS SQUIBB CO (BMY)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
12 Mar 2026, 16:23:04 UTC
Prior SEC filing
05 Aug 2025
Next SEC filing
04 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Amy Fallone, attorney-in-fact for Cristian Massacesi

Key filing fact

Cristian Massacesi filed Form 4 for BRISTOL MYERS SQUIBB CO (BMY) on 12 Mar 2026.

Key facts

  • This page summarizes Cristian Massacesi's Form 4 filing for BRISTOL MYERS SQUIBB CO (BMY).
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 12 Mar 2026, 16:23.

Change

  • Previous filing in this sequence was filed on 05 Aug 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002080176 Primary reporting owner

Massacesi Cristian

Relationship
EVP,Chief Med Offr,Head of Dev
Address
BRISTOL-MYERS SQUIBB COMPANY, ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON
Signature
/s/ Amy Fallone, attorney-in-fact for Cristian Massacesi
Signature date
12 Mar 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BMY transaction Derivative

Market Share Units

Award

Transaction value
Shares
+26,122
Change %
Price
$0.000000*
Shares after
26,122
Date
10 Mar 2026
Ownership
Direct
Underlying class
Common Stock, $0.10 par value
Underlying amount
26,122
Exercise price
Footnotes
F1, F2
BMY transaction Derivative

Performance Shares

Award

Transaction value
Shares
+39,184
Change %
Price
$0.000000*
Shares after
39,184
Date
10 Mar 2026
Ownership
Direct
Underlying class
Common Stock, $0.10 par value
Underlying amount
39,184
Exercise price
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is the greater of Total Return and relative total shareholder return (rTSR) Floor. Total Return is a ratio of the 10-day average closing stock price on the measurement date, plus the value of accumulated dividends, divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor for Total Return performance that must be achieved to earn a payout is 80% and the maximum is 225%. The rTSR Floor feature provides a minimum level of payout if BMS stock price declines from the grant date but outperforms our peers based on their TSR percentile rank. A TSR percentile rank (i) below the 50th percentile yields a 0% payout, (ii) between the 50th and 74.99th percentiles yields a 50% payout, and (iii) at or above the 75th percentile yields a 100% payout.

Footnote F2

These market share units cliff vest on the third anniversary of the grant date, subject to certification of performance results by the Board.

Footnote F3

Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2029, subject to certification of performance results by the Board.

SEC remarks

Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .